bioXXmed AG (FRA:T5O)
Germany flag Germany · Delayed Price · Currency is EUR
1.330
+0.030 (2.31%)
At close: Jan 30, 2026

bioXXmed AG Balance Sheet

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
0.080.250.611.8401.57
Cash & Short-Term Investments
0.080.250.611.8401.57
Cash Growth
-11.97%-58.58%-66.69%347701.70%-99.97%-21.88%
Other Receivables
0.020-0.040.040
Receivables
0.020-0.040.040
Other Current Assets
0.040.070.070.050.060.11
Total Current Assets
0.140.330.681.940.11.68
Property, Plant & Equipment
-00000.01
Long-Term Investments
0.160.16019.6518.1520.5
Other Intangible Assets
-00000.05
Other Long-Term Assets
0.01--0.020.010.04
Total Assets
0.310.490.6821.6118.2722.3
Accounts Payable
-0.080.090.030.10.1
Accrued Expenses
0.05--0.050.050.22
Current Income Taxes Payable
0--0.040.04-
Other Current Liabilities
0.01--0.010.080.04
Total Current Liabilities
0.070.080.090.140.270.36
Long-Term Debt
0.14-0.01-0.12-
Other Long-Term Liabilities
0.040.090.110.050.010.01
Total Liabilities
0.240.170.210.190.40.37
Common Stock
1.361.365.145.144.034.03
Additional Paid-In Capital
----34.02-
Retained Earnings
-43.65-43.4-42.4-21.45-20.62-16.56
Comprehensive Income & Other
42.3642.3637.7337.730.4434.46
Shareholders' Equity
0.060.320.4721.4217.8721.93
Total Liabilities & Equity
0.310.490.6821.6118.2722.3
Total Debt
0.14-0.01-0.12-
Net Cash (Debt)
-0.060.250.611.84-0.121.57
Net Cash Growth
--58.08%-67.09%---21.88%
Net Cash Per Share
-0.210.935.8917.91-1.5019.50
Filing Date Shares Outstanding
0.270.270.10.10.080.08
Total Common Shares Outstanding
0.270.270.10.10.080.08
Working Capital
0.070.250.591.8-0.171.32
Book Value Per Share
0.231.174.57208.46221.78272.16
Tangible Book Value
0.060.320.4721.4217.8721.87
Tangible Book Value Per Share
0.231.174.57208.46221.78271.50
Machinery
-0.010.010.01-0.04
Source: S&P Global Market Intelligence. Standard template. Financial Sources.